Page last updated: 2024-10-27

flecainide and Amylopectinosis

flecainide has been researched along with Amylopectinosis in 1 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fox, DJ1
Klein, GJ1
Hahn, A1
Skanes, AC1
Gula, LJ1
Yee, RK1
Subbiah, RN1
Krahn, AD1

Other Studies

1 other study available for flecainide and Amylopectinosis

ArticleYear
Reduction of complex ventricular ectopy and improvement in exercise capacity with flecainide therapy in Andersen-Tawil syndrome.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2008, Volume: 10, Issue:8

    Topics: Anti-Arrhythmia Agents; Drug Therapy, Combination; Exercise Test; Exercise Tolerance; Flecainide; Gl

2008